Centers for Medicare and Medicaid Services — Lanton Law Blog

CMS Makes An Impactful Change Regarding Biosimilars

Within its final calendar year 2025 Medicare Advantage and Part D final rule seen here, the Centers for Medicare and Medicaid Servces (CMS) is allowing Part D sponsors the ability to make midyear substitutions of biosimilars for their reference products on their formularies.

biologics, Biosimilars, biotechnology, biotech, healthcare, insurance, pharmaceuticalsRon LantonApril 8, 2024biosimilars, CMS, Centers for Medicare and Medicaid Services, insurance, healthcare

Biden Administration Issues Interim Final Rule on Surprise Medical Billing

The Centers for Medicare and Medicaid Services (CMS) in conjunction with the Departments of Health and Human Services (HHS), Labor (DOL), Treasury (collectively, the Departments), and the Office of Personnel Management (OPM) has issued an interim final rule with a comment period that seeks to implement the No Surprises Act aimed at surprise medical billing.

surprise medical billing, Administration, White House, pharmaceuticals, life sciences, healthcare, health system, hospitals, CMSRon LantonOctober 5, 2021Centers for Medicare and Medicaid Services, Departments of Health and Human Services (HHS), Department of Labor, Treasury, OPM, Office of Personnel Management, surprise medical billing

CMS Proposes Rescinding Most Favored Nation Interim Final Rule

The Centers for Medicare and Medicaid Services (CMS) has released a proposed rule that seeks to rescind the Most Favored Nation Model interim final rule with comment period that appeared in the November 27, 2020 Federal Register. CMS is seeking public comment by October 12, 2021.